0000899243-20-011277.txt : 20200424
0000899243-20-011277.hdr.sgml : 20200424
20200424161005
ACCESSION NUMBER: 0000899243-20-011277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200422
FILED AS OF DATE: 20200424
DATE AS OF CHANGE: 20200424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chapman Marcus
CENTRAL INDEX KEY: 0001770404
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37465
FILM NUMBER: 20815044
MAIL ADDRESS:
STREET 1: C/O SERES THERAPEUTICS, INC.
STREET 2: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seres Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274326290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 945 9626
MAIL ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Seres Health, Inc.
DATE OF NAME CHANGE: 20140603
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-22
0
0001609809
Seres Therapeutics, Inc.
MCRB
0001770404
Chapman Marcus
C/O SERES THERAPEUTICS, INC.
200 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
See Remarks
STOCK OPTION (RIGHT TO BUY)
3.74
2020-04-22
4
A
0
18596
0.00
A
2030-04-21
Common Stock
18596
18596
D
The option will vest in full on April 22, 2021.
SVP, Principal Financial and Accounting Officer
/s/ Thomas J. DesRosier, Attorney-in-fact for Marcus Chapman
2020-04-24